944 total citations 38 papers, 787 citations indexed
About
Prout Gr is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Urology.
According to data from OpenAlex, Prout Gr has authored 38 papers receiving a total of 787 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Urology. Recurrent topics in Prout Gr's work include Bladder and Urothelial Cancer Treatments (15 papers), Urological Disorders and Treatments (6 papers) and Hormonal and reproductive studies (5 papers). Prout Gr is often cited by papers focused on Bladder and Urothelial Cancer Treatments (15 papers), Urological Disorders and Treatments (6 papers) and Hormonal and reproductive studies (5 papers). Prout Gr collaborates with scholars based in United States. Prout Gr's co-authors include Saul Boyarsky, Paulson Df, Graeme Jones, Sandberg Aa, Pontes Je, Zenon Gibas, Chu Tm, Scott Ww, Murphy Gp and R. J. Irwin and has published in prestigious journals such as PubMed.
In The Last Decade
Prout Gr
37 papers
receiving
718 citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Prout Gr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prout Gr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prout Gr more than expected).
This network shows the impact of papers produced by Prout Gr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prout Gr. The network helps show where Prout Gr may publish in the future.
Co-authorship network of co-authors of Prout Gr
This figure shows the co-authorship network connecting the top 25 collaborators of Prout Gr.
A scholar is included among the top collaborators of Prout Gr based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Prout Gr. Prout Gr is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Gr, Prout, et al.. (1990). A progress report on the results of multimodality therapy for muscle-invasive bladder cancer.. PubMed. 8(3). 201–4.2 indexed citations
2.
Irwin, Richard S., et al.. (1989). Treatment modalities in superficial bladder cancer.. PubMed. 7(1 Suppl 1). 1–12.7 indexed citations
3.
Gr, Prout, et al.. (1988). The role of radiation therapy and chemotherapy in the treatment of invasive carcinoma of the urinary bladder.. PubMed. 15(4). 390–5.7 indexed citations
4.
Gibas, Zenon, et al.. (1984). Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.. PubMed. 44(3). 1257–64.149 indexed citations
5.
Gr, Prout, et al.. (1981). Nodal involvement as prognostic indicator in prostatic carcinoma.. PubMed. 17(Suppl 3). 72–9.8 indexed citations
6.
Gr, Prout, et al.. (1980). Experimental ureteral lengthening in dogs.. PubMed. 18(1). 66–8.2 indexed citations
7.
Kliman, Bernard, et al.. (1979). Measurement of androgen receptor in cytosol of human prostatic tissues with a sepharose-linked antibody system.. PubMed. 33. 85–96.3 indexed citations
8.
Gr, Prout, et al.. (1979). Identification of malignant transitional cells by their binding of fluorescein-labeled lectin.. PubMed. 30. 565–7.2 indexed citations
9.
Gr, Prout, et al.. (1979). New assay for cytotoxic agents in human bladder cancer.. PubMed. 30. 560–2.6 indexed citations
10.
Gr, Prout, et al.. (1978). In vivo growth of human bladder cancer cell lines.. PubMed. 15(5). 380–4.3 indexed citations
11.
Gr, Prout, et al.. (1978). Galactosyl transferase in benign and neoplastic human bladder mucosa.. PubMed. 29. 627–9.1 indexed citations
12.
Tm, Chu, et al.. (1978). Immunochemical detection of serum prostatic acid phosphatase. Methodology and clinical evaluation.. PubMed. 15(4). 319–23.83 indexed citations
13.
Ww, Scott, Prout Gr, Chu Tm, et al.. (1977). National randomized study of chemotherapeutic agents in advanced prostatic carcinoma: a progress report.. PubMed. 61(2). 317–23.43 indexed citations
14.
Boyarsky, Saul, Graeme Jones, Paulson Df, & Prout Gr. (1976). A new look at bladder neck obstruction by the food and drug administration regulators: guide lines for investigation of benign prostatic hypertrophy.. PubMed. 68. 29–32.191 indexed citations
15.
Gr, Prout, et al.. (1972). Proceedings: Preoperative irradiation and cystectomy for bladder carcinoma. IV. Results in a selected population.. PubMed. 7. 783–91.6 indexed citations
16.
Gr, Prout, et al.. (1970). Bladder regeneration following serosal colocystoplasty.. PubMed. 8(2). 170–6.2 indexed citations
17.
Gr, Prout, et al.. (1970). Effect of orchiectomy and various doses of stilbestrol on plasma testosterone levels in patients with carcinoma of the prostate.. PubMed. 21. 540–1.15 indexed citations
18.
Gr, Prout, et al.. (1964). ALTERATIONS IN SERUM LACTIC DEHYDROGENASE AND ITS ISOZYMES IN PATIENTS WITH PROSTATIC CARCINOMA AFTER HORMONAL THERAPY.. PubMed. 15. 486–8.3 indexed citations
19.
Gr, Prout, et al.. (1962). Alterations in the isozymes of lactic dehydrogenase in the canine prostate after androgenic stimulation.. PubMed. 13. 515–6.1 indexed citations
20.
Gr, Prout, et al.. (1961). Some laboratory and clinical observations on coly-mycin (colistin) with particular reference to Pseudomonas infections.. PubMed. 112. 211–7.8 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.